RadiolysisStabilityChecker

Radiolysis Stability Checker

radiopharmaceuticals QC URS & FS input.csv output.json alpha therapy radiochemical purity radionuclidic purity
Open selection

Utility description: Radiolysis Stability Checker

Radiolysis Stability Checker — Radiopharmaceutical Stability Assessment

ℹ️  Predicts RCP drop due to autoradiolysis based on activity, volume, and time.
ℹ️  Accounts for radioprotectors (ascorbate, ethanol).

Usage:
  RadiolysisStabilityChecker.exe                            → demo mode
  RadiolysisStabilityChecker.exe input.csv output.json      → calculation

Input format:
BatchNumber,Radiopharmaceutical,Initial_Activity_MBq,Volume_mL,Initial_RCP_Percent,Has_Radioprotector,Radioprotector_Type,Radioprotector_Concentration_mM,EOS_Time_ISO,Check_Time_ISO,Radionuclide

Example:
LU177-STAB-001,Lu-177-DOTATATE,7400.0,5.0,99.5,true,Ascorbic,10.0,2026-05-20T08:00:00,2026-05-20T16:00:00,Lu-177

— WHY IS THIS NEEDED?
At high specific activities, radiopharmaceuticals are subject to radiolysis — self-decomposition by their own radiation.
• Prediction: The utility estimates how much Radiochemical Purity (RCP) will drop by the time of injection or expiration.
• Risk Factors: High activity concentration (MBq/mL), lack of radioprotectors, long storage times.
• Alpha Emitters (Ac-225): Have high LET (Linear Energy Transfer), causing rapid radiolysis even at low activities.
• Radioprotectors: Ascorbic acid, gentisic acid, or ethanol significantly slow down degradation.

⚠️ IMPORTANT:
• The model is simplified. Real radiolysis kinetics are complex and depend on many factors (pH, impurities, vial material).
• Use this tool for preliminary assessment and logistics planning.
• Always confirm RCP experimentally (TLC/HPLC) before patient administration.

input.csv

BatchNumber,Radiopharmaceutical,Initial_Activity_MBq,Volume_mL,Initial_RCP_Percent,Has_Radioprotector,Radioprotector_Type,Radioprotector_Concentration_mM,EOS_Time_ISO,Check_Time_ISO,Radionuclide
LU177-STAB-001,Lu-177-DOTATATE,7400.0,5.0,99.5,true,Ascorbic,10.0,2026-05-20T08:00:00,2026-05-20T16:00:00,Lu-177
AC225-STAB-001,Ac-225-PSMA,10.0,1.0,98.0,false,None,0.0,2026-05-20T08:00:00,2026-05-20T12:00:00,Ac-225

URS & FS — User Requirements and Functional Specification

1. Scope

This document defines requirements and functional behaviour for RadiolysisStabilityChecker used to control: Radiolysis Stability Checker. The utility is intended for QC use and applies deterministic rules, not machine learning.

2. Execution modes

  • RadiolysisStabilityChecker.exe — demo mode or help output.
  • RadiolysisStabilityChecker.exe input.csv output.json — process user data and write result.

3. Key source-derived controls

  • Radiolysis Stability Checker — Radiopharmaceutical Stability Assessment
  • BatchNumber,Radiopharmaceutical,Initial_Activity_MBq,Volume_mL,Initial_RCP_Percent,Has_Radioprotector,Radioprotector_Type,Radioprotector_Concentration_mM,EOS_Time_ISO,Check_Time_ISO,Radionuclide
  • At high specific activities, radiopharmaceuticals are subject to radiolysis — self-decomposition by their own radiation.
  • • Prediction: The utility estimates how much Radiochemical Purity (RCP) will drop by the time of injection or expiration.
  • • Alpha Emitters (Ac-225): Have high LET (Linear Energy Transfer), causing rapid radiolysis even at low activities.
  • ⚠️ IMPORTANT:
  • • The model is simplified. Real radiolysis kinetics are complex and depend on many factors (pH, impurities, vial material).

4. URS — user requirements

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept input.csv with the exact headers defined in the data contract.HighThe file is processed without manual header changes.
URS-002The utility shall validate mandatory fields, data types, ranges, units, and critical pharmaceutical/radiochemical limits.HighEach row receives PASS/WARNING/FAIL status.
URS-003The utility shall detect critical deviations related to radionuclidic/radiochemical purity, impurities, free radionuclide, pH, endotoxins and sterility where such fields are present.HighA critical deviation produces FAIL or an explicit critical finding.
URS-004The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-005The utility shall not use machine learning to decide conformance.MediumThe decision is based on explicit rules and thresholds.
URS-006The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains batch identifier and checked parameters.
URS-007The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulator.MediumURS/FS and test scenarios are supplied with the utility.

5. input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringLU177-STAB-001Batch or lot identifier.
2RadiopharmaceuticalstringLu-177-DOTATATEProduct/radiopharmaceutical type; affects control interpretation.
3Initial_Activity_MBqdecimal7400.0Activity of the radiopharmaceutical material or finished product.
4Volume_mLdecimal5.0Controlled input parameter from input.csv.
5Initial_RCP_Percentdecimal99.5Controlled input parameter from input.csv.
6Has_RadioprotectordecimaltrueControlled input parameter from input.csv.
7Radioprotector_TypestringAscorbicControlled input parameter from input.csv.
8Radioprotector_Concentration_mMdecimal10.0Controlled input parameter from input.csv.
9EOS_Time_ISOdecimal2026-05-20T08:00:00Controlled input parameter from input.csv.
10Check_Time_ISOdecimal2026-05-20T16:00:00Controlled input parameter from input.csv.
11RadionuclidedecimalLu-177Controlled input parameter from input.csv.
BatchNumber,Radiopharmaceutical,Initial_Activity_MBq,Volume_mL,Initial_RCP_Percent,Has_Radioprotector,Radioprotector_Type,Radioprotector_Concentration_mM,EOS_Time_ISO,Check_Time_ISO,Radionuclide
LU177-STAB-001,Lu-177-DOTATATE,7400.0,5.0,99.5,true,Ascorbic,10.0,2026-05-20T08:00:00,2026-05-20T16:00:00,Lu-177
AC225-STAB-001,Ac-225-PSMA,10.0,1.0,98.0,false,None,0.0,2026-05-20T08:00:00,2026-05-20T12:00:00,Ac-225

6. FS — functional specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format; validate header and expected columns.
FS-002Schema validationValidate mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; record invalid format as row-level error.
FS-004Rule engineApply domain rules for Radiolysis Stability Checker, including critical limits from the utility description.
FS-005Status aggregationGenerate final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with check details, source values, warnings and critical findings.
FS-007Audit supportKeep result structure suitable for review, deviation investigation and IQ/OQ preparation.

7. output.json example

{
  "utilityId": "radiolysis-stability-checker",
  "api": "Radiolysis Stability Checker",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "LU177-STAB-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Radiopharmaceutical",
      "value": "Lu-177-DOTATATE",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Initial_Activity_MBq",
      "value": "7400.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Volume_mL",
      "value": "5.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Initial_RCP_Percent",
      "value": "99.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Has_Radioprotector",
      "value": "true",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Radioprotector_Type",
      "value": "Ascorbic",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Radioprotector_Concentration_mM",
      "value": "10.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

8. OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to rules.
OQ-002Mandatory column is missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotApproved review result with input.csv and output.json retained.

9. QA/QC and change control

  • Do not rename columns without validator update.
  • Store input.csv, output.json, executable version and checksum.
  • Before production use perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be checked against the approved specification and local SOPs.

Included in packages

PetRad2: advanced radiopharmaceutical QC package

A curated set of new utilities for radionuclide control, targeted alpha therapy, specific activity, radiolysis stability and preliminary dosimetry calculations.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH organ/system: endocrine, thyroid and NET

Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH use case: radionuclide therapy and theranostics

Lu-177, Ac-225, Ra-223, Y-90, Ho-166, Sm-153, Sr-89, Re-188, Tb-161, I-131 and other therapeutic radiopharmaceuticals: activity, purity, free metal, daughters and toxicological constraints.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open